Genetic variations of hepatitis B virus and serum aflatoxin-lysine adduct on high risk of hepatocellular carcinoma in Southern Guangxi, China

Journal of Hepatology

Volumn 53, Issue 4, 2010, Pages 671-676

  Xu, Li ^a   Qian, Guoqing ^a   Tang, Lili ^a   Su, Jianjia ^b   Wang, Jia Sheng ^a  

^a UNIVERSITY OF GEORGIA   (United States)

^b Guangxi Cancer Institute   (China)

Author keywords

Aflatoxin lysine adduct; BCP mutations; Genotype; Hepatitis B virus; Hepatocellular carcinoma

Indexed keywords

AFLATOXIN B1; LYSINE;

ADULT; AGE DISTRIBUTION; ARTICLE; CANCER RISK; CHINA; CONTROLLED STUDY; DIETARY INTAKE; DNA ADDUCT; DRUG EXPOSURE; FEMALE; FLUORESCENCE; GENE MUTATION; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HEPATITIS B VIRUS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HIGH RISK PATIENT; HOME; HUMAN; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; SEX DIFFERENCE;

ADULT; AFLATOXIN B1; CARCINOMA, HEPATOCELLULAR; CASE-CONTROL STUDIES; CHINA; ENVIRONMENTAL EXPOSURE; FEMALE; GENOTYPE; HEPATITIS B VIRUS; HUMANS; LIVER NEOPLASMS; LYSINE; MALE; MIDDLE AGED; RISK FACTORS;

EID: 77956268034     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2010.04.032     Document Type: Article

References (42)

1. M. Garcia, A. Jemal, E.M. Ward, M.M. Center, and Y. Hao Global cancer facts & figures 2007 2007 American Cancer Society Atlanta, GA
2. J.H. Kao Hepatitis B viral genotypes: clinical relevance and molecular characteristics J Gastroenterol Hepatol 17 2002 643 650
3. S.Y. Kuang, P.E. Jackson, J.B. Wang, P.X. Lu, A. Munoz, and G.S. Qian Specific mutations of hepatitis B virus in plasma predict liver cancer development Proc Natl Acad Sci USA 101 2004 3575 3580
4. Y. Miyakawa, and M. Mizokami Classifying hepatitis B virus genotypes Intervirology 46 2003 329 338
5. H.L. Chan, A.Y. Hui, M.L. Wong, A.M. Tse, L.C. Hung, and V.W. Wong Genotype C hepatitis B virus infection is associated with an increased risk of hepatocellular carcinoma Gut 53 2004 1494 1498
6. O.M. Andrisani, and S. Barnabas The transcriptional function of the hepatitis B virus X protein and its role in hepatocarcinogenesis (Review) Int J Oncol 15 1999 373 379
7. S. Gunther, N. Piwon, and H. Will Wild-type levels of pregenomic RNA and replication but reduced pre-C RNA and e-antigen synthesis of hepatitis B virus with C(1653) → T, A(1762) → T and G(1764) → A mutations in the core promoter J Gen Virol 79 1998 375 380
8. S. Jammeh, F. Tavner, R. Watson, H.C. Thomas, and P. Karayiannis Effect of basal core promoter and pre-core mutations on hepatitis B virus replication J Gen Virol 89 2008 901 909
9. Z.L. Fang, C.A. Sabin, B.Q. Dong, L.Y. Ge, S.C. Wei, and Q.Y. Chen HBV A1762T, G1764A mutations are a valuable biomarker for identifying a subset of male HBsAg carriers at extremely high risk of hepatocellular carcinoma: a prospective study Am J Gastroenterol 103 2008 2254 2262
10. J.M. Yuan, A. Ambinder, Y. Fan, Y.T. Gao, M.C. Yu, and J.D. Groopman Prospective evaluation of hepatitis B 1762(T)/1764(A) mutations on hepatocellular carcinoma development in Shanghai, China Cancer Epidemiol Biomarkers Prev 18 2009 590 594
11. J.G. Chen, S.Y. Kuang, P.A. Egner, J.H. Lu, Y.R. Zhu, and J.B. Wang Acceleration to death from liver cancer in people with hepatitis B viral mutations detected in plasma by mass spectrometry Cancer Epidemiol Biomarkers Prev 16 2007 1213 1218
12. S.Y. Kuang, S. Lekawanvijit, N. Maneekarn, S. Thongsawat, K. Brodovicz, and K. Nelson Hepatitis B 1762T/1764A mutations, hepatitis C infection, and codon 249 p53 mutations in hepatocellular carcinomas from Thailand Cancer Epidemiol Biomarkers Prev 14 2005 380 384
13. J. Hou, G.K. Lau, J. Cheng, C.C. Cheng, K. Luo, and W.F. Carman T1762/A1764 variants of the basal core promoter of hepatitis B virus; serological and clinical correlations in Chinese patients Liver 19 1999 411 417
14. Y. Tanaka, M. Mukaide, E. Orito, M.F. Yuen, K. Ito, and F. Kurbanov Specific mutations in enhancer II/core promoter of hepatitis B virus subgenotypes C1/C2 increase the risk of hepatocellular carcinoma J Hepatol 45 2006 646 653
15. K. Takahashi, Y. Ohta, K. Kanai, Y. Akahane, Y. Iwasa, and K. Hino Clinical implications of mutations C-to-T1653 and T-to-C/A/G1753 of hepatitis B virus genotype C genome in chronic liver disease Arch Virol 144 1999 1299 1308
16. M.F. Yuen, Y. Tanaka, N. Shinkai, R.T. Poon, D.Y. But, and D.Y. Fong Risk for hepatocellular carcinoma with respect to hepatitis B virus genotypes B/C, specific mutations of enhancer II/core promoter/precore regions and HBV DNA levels Gut 57 2008 98 102
17. F.S. Yeh, C.C. Mo, and R.C. Yen Risk factors for hepatocellular carcinoma in Guangxi, People's Republic of China Natl Cancer Inst Monogr 69 1985 47 48
18. F.S. Yeh, M.C. Yu, C.C. Mo, S. Luo, M.J. Tong, and B.E. Henderson Hepatitis B virus, aflatoxins, and hepatocellular carcinoma in southern Guangxi, China Cancer Res 49 1989 2506 2509
19. J.M. Yuan, S. Govindarajan, B.E. Henderson, and M.C. Yu Low prevalence of hepatitis C infection in hepatocellular carcinoma (HCC) cases and population controls in Guangxi, a hyperendemic region for HCC in the People's Republic of China Br J cancer 74 1996 491 493
20. K. Makarananda, U. Pengpan, M. Srisakulthong, K. Yoovathaworn, and K. Sriwatanakul Monitoring of aflatoxin exposure by biomarkers J Toxicol Sci 23 1998 155 159
21. J.D. Groopman, D. Johnson, and T.W. Kensler Aflatoxin and hepatitis B virus biomarkers: a paradigm for complex environmental exposures and cancer risk Cancer Biomark 1 2005 5 14
22. M. Rozanov, U. Plikat, C. Chappey, A. Kochergin, and T. Tatusova A web-based genotyping resource for viral sequences Nucleic Acids Res 32 2004 W654 W659
23. J.S. Wang, G.S. Qian, A. Zarba, X. He, Y.R. Zhu, and B.C. Zhang Temporal patterns of aflatoxin-albumin adducts in hepatitis B surface antigen-positive and antigen-negative residents of Daxin, Qidong County, People's Republic of China Cancer Epidemiol Biomarkers Prev 5 1996 253 261
24. R.M. Mickey, and S. Greenland The impact of confounder selection criteria on effect estimation Am J Epidemiol 129 1989 125 137
25. J. Yin, H. Zhang, C. Li, C. Gao, Y. He, and Y. Zhai Role of hepatitis B virus genotype mixture, subgenotypes C2 and B2 on hepatocellular carcinoma: compared with chronic hepatitis B and asymptomatic carrier state in the same area Carcinogenesis 29 2008 1685 1691
26. G. Zeng, Z. Wang, S. Wen, J. Jiang, L. Wang, and J. Cheng Geographic distribution, virologic and clinical characteristics of hepatitis B virus genotypes in China J Viral Hepat 12 2005 609 617
27. Y. Dong, S.L. Liu, X.J. Zhai, F.C. Zhu, H. Pan, and J.X. Yu A serological and molecular survey of hepatitis B in children 15 years after inception of the national hepatitis B vaccination program in eastern China J Med Virol 81 2009 1517 1524
28. K. Hayashi, Y. Katano, T.X. Chuong, Y. Takeda, M. Ishigami, and A. Itoh Prevalence of hepatitis B virus subgenotypes and basal core promoter, precore variants in patients with acute hepatitis B in central Vietnam Intervirology 52 2009 22 28
29. B.X. Truong, Y. Seo, Y. Yano, P.T. Ho, T.M. Phuong, and D.V. Long Genotype and variations in core promoter and pre-core regions are related to progression of disease in HBV-infected patients from Northern Vietnam Int J Mol Med 19 2007 293 299
30. Z.L. Fang, H. Zhuang, X.Y. Wang, X.M. Ge, and T.J. Harrison Hepatitis B virus genotypes, phylogeny and occult infection in a region with a high incidence of hepatocellular carcinoma in China World J Gastroenterol 10 2004 3264 3268
31. Y.H. Ni, M.H. Chang, K.J. Wang, H.Y. Hsu, H.L. Chen, and J.H. Kao Clinical relevance of hepatitis B virus genotype in children with chronic infection and hepatocellular carcinoma Gastroenterology 127 2004 1733 1738
32. X. Guo, Y. Jin, G. Qian, and H. Tu Sequential accumulation of the mutations in core promoter of hepatitis B virus is associated with the development of hepatocellular carcinoma in Qidong, China J Hepatol 49 2008 718 725
33. E. Orito, M. Mizokami, H. Sakugawa, K. Michitaka, K. Ishikawa, and T. Ichida A case-control study for clinical and molecular biological differences between hepatitis B viruses of genotypes B and C. Japan HBV Genotype Research Group Hepatology 33 2001 218 223
34. H.I. Yang, S.H. Yeh, P.J. Chen, U.H. Iloeje, C.L. Jen, and J. Su Associations between hepatitis B virus genotype and mutants and the risk of hepatocellular carcinoma J Natl Cancer Inst 100 2008 1134 1143
35. M. Baptista, A. Kramvis, and M.C. Kew High prevalence of 1762(T) 1764(A) mutations in the basic core promoter of hepatitis B virus isolated from black Africans with hepatocellular carcinoma compared with asymptomatic carriers Hepatology 29 1999 946 953
36. IARC. Some naturally occurring substances: food items and constituents, heterocyclic aromatic amines and mycotoxins. 1993;245-395.
37. R.K. Ross, J.M. Yuan, M.C. Yu, G.N. Wogan, G.S. Qian, and J.T. Tu Urinary aflatoxin biomarkers and risk of hepatocellular carcinoma Lancet 339 1992 943 946
38. L.Y. Wang, M. Hatch, C.J. Chen, B. Levin, S.L. You, and S.N. Lu Aflatoxin exposure and risk of hepatocellular carcinoma in Taiwan Int J Cancer 67 1996 620 625
39. C.J. Chen, L.Y. Wang, S.N. Lu, M.H. Wu, S.L. You, and Y.J. Zhang Elevated aflatoxin exposure and increased risk of hepatocellular carcinoma Hepatology 24 1996 38 42
40. C.P. Wild, and R. Montesano A model of interaction: aflatoxins and hepatitis viruses in liver cancer aetiology and prevention Cancer Lett 286 2009 22 28
41. J.D. Groopman, J.Q. Zhu, P.R. Donahue, A. Pikul, L.S. Zhang, and J.S. Chen Molecular dosimetry of urinary aflatoxin-DNA adducts in people living in Guangxi Autonomous Region, People's Republic of China Cancer Res 52 1992 45 52
42. J.S. Wang, T. Huang, J. Su, F. Liang, Z. Wei, and Y. Liang Hepatocellular carcinoma and aflatoxin exposure in Zhuqing Village, Fusui County, People's Republic of China Cancer Epidemiol Biomarkers Prev 10 2001 143 146